Discover your unique microbiome profile with advanced testing

Learn More →
Bile Acid Metabolites

Ursodeoxycholic Acid (UDCA)

Ursodeoxycholic acid is a therapeutic secondary bile acid with hepatoprotective, anti-inflammatory, and immunomodulatory properties. It's used to treat various liver and gallbladder conditions.

Beneficial
Liver Health Gallstones Anti-inflammatory Therapeutic
FDA
Approved medication
3%
Of human bile acid pool
Bears
Originally from bear bile

Health Effect: Beneficial

This metabolite is generally associated with positive health outcomes.

Production Pathway

Precursors
Chenodeoxycholic acid7-ketolithocholic acid (intermediate)
Bacteria
ClostridiumRuminococcus
Metabolite
Ursodeoxycholic Acid (UDCA)

Producing Bacteria

Clostridium species View details →
Ruminococcus species View details →
Eubacterium species

Affected Body Systems

This metabolite influences the following body systems:

Hepatic Digestive Immune

Ursodeoxycholic acid (UDCA, also called ursodiol) stands apart from other secondary bile acids. While deoxycholic acid and lithocholic acid have concerning effects at high levels, UDCA is distinctly hepatoprotective and is actually used as a medication to treat liver and gallbladder diseases [^paumgartner2002].

A Therapeutic Bile Acid

Historical Background

UDCA gets its name from its discovery in bear bile (Latin: ursus = bear). Bear bile has been used in traditional Chinese medicine for centuries to treat liver and eye diseases. Modern science has validated UDCA's therapeutic properties, leading to synthetic production for pharmaceutical use.

Natural Production

While your gut bacteria do produce small amounts of UDCA (about 3% of the total bile acid pool), therapeutic doses require supplementation:

Bacterial Production Pathway:

  1. Chenodeoxycholic acid (CDCA) reaches the colon
  2. Bacteria convert CDCA to 7-ketolithocholic acid
  3. Further bacterial transformation produces UDCA

The limited natural production is why UDCA supplementation is necessary for therapeutic effects.

Mechanisms of Action

UDCA benefits health through multiple mechanisms [^lazaridis2001]:

Hepatoprotection

  • Displaces toxic bile acids: UDCA is hydrophilic (water-loving) compared to other bile acids, making it less damaging to cell membranes
  • Stabilizes cell membranes: Protects liver cells from bile acid-induced damage
  • Reduces oxidative stress: Antioxidant properties protect hepatocytes

Choleretic Effect

  • Stimulates bile flow from the liver
  • Enhances secretion of bile acids and other compounds
  • Helps prevent bile stasis

Immunomodulation

  • Reduces expression of HLA class I molecules
  • Decreases cytokine production
  • May help in autoimmune liver conditions

Anti-Apoptotic Effects

  • Protects liver cells from programmed cell death
  • May help preserve liver function in disease states

Medical Uses

FDA-Approved Indications

Primary Biliary Cholangitis (PBC)

UDCA is the first-line treatment for PBC:

  • Improves liver biochemistry
  • Slows disease progression
  • May reduce need for liver transplantation

Gallstone Dissolution

UDCA can dissolve cholesterol gallstones:

  • Works best for small (<1.5 cm), cholesterol-rich stones
  • Requires months of treatment
  • Alternative to surgery for some patients

Off-Label Uses

Non-Alcoholic Fatty Liver Disease (NAFLD)

  • Some evidence of benefit
  • May improve liver enzymes
  • Research ongoing

Primary Sclerosing Cholangitis (PSC)

  • Used despite limited evidence of benefit
  • May improve liver biochemistry
  • Does not clearly prevent disease progression

Intrahepatic Cholestasis of Pregnancy

  • Can relieve itching
  • May improve fetal outcomes
  • Generally considered safe in pregnancy

Cystic Fibrosis-Related Liver Disease

  • May slow progression of liver disease
  • Commonly used in CF patients with liver involvement

UDCA vs. Other Bile Acids

Property UDCA DCA LCA
Hydrophilicity High Low Very low
Membrane toxicity Low Moderate High
Cancer association Protective? Risk factor Risk factor
Therapeutic use Yes Limited No
Natural abundance ~3% ~20% ~5%

How UDCA Supplements Work

When you take UDCA supplements:

  1. Oral UDCA is absorbed in the small intestine
  2. It enters the enterohepatic circulation
  3. Gradually replaces more toxic bile acids in the bile acid pool
  4. At therapeutic doses, UDCA becomes 40-50% of total bile acids
  5. This "dilutes" the effects of harmful bile acids

Dosing

  • Typical dose: 13-15 mg/kg/day
  • Usually divided into 2-3 doses
  • Taken with food for better absorption

Potential Side Effects

UDCA is generally well-tolerated:

  • Diarrhea (most common)
  • Nausea
  • Abdominal discomfort
  • Rarely: gallstone calcification (making them non-dissolvable)

Testing Bile Acid Levels

While UDCA levels aren't typically tested clinically (since most UDCA comes from supplements), bile acid testing can be useful:

  • Pre-treatment assessment: Evaluate overall bile acid status
  • Monitor response: In some conditions
  • Research settings: Understanding microbiome-bile acid interactions

Boosting Natural UDCA Production

While natural UDCA production is limited, supporting the bacteria involved may be beneficial:

Dietary Strategies

  • High-fiber diet supports diverse bacterial communities
  • Fermented foods may help
  • Avoid unnecessary antibiotics that deplete bile acid-transforming bacteria

Probiotics

Some research suggests certain probiotics may influence bile acid metabolism, though specific UDCA-boosting strains aren't well-established.

Future Directions

Research Areas

  • UDCA analogs with improved properties
  • Combination therapies for liver disease
  • Role in colorectal cancer prevention
  • Understanding microbiome influences on UDCA production

Emerging Applications

  • Potential neuroprotective effects
  • Possible benefits in inflammatory bowel disease
  • Investigation in metabolic disorders

Important Considerations

When to Consider UDCA

UDCA should be prescribed by a healthcare provider for:

  • Diagnosed liver or gallbladder conditions
  • Specific indications where benefit is established
  • Appropriate monitoring can occur

Not for Self-Treatment

Despite its safety profile, UDCA:

  • Requires proper diagnosis first
  • Needs appropriate dosing
  • Should be monitored for response
  • May interact with other medications

If you're interested in UDCA for a specific condition, discuss with a gastroenterologist or hepatologist who can evaluate your situation and monitor treatment appropriately.

Dietary Precursors

Increase these in your diet to boost production:

Chenodeoxycholic acid 7-ketolithocholic acid (intermediate)

How to Test Your Levels

Available testing methods for Ursodeoxycholic Acid (UDCA):

  • Serum bile acid panel
  • Stool bile acid analysis
Explore testing options

References

  1. Paumgartner G, Beuers U.. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36(3):525-531. doi:10.1053/jhep.2002.36088
  2. Lazaridis KN, Gores GJ, Lindor KD.. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol. 2001;35(1):134-146. doi:10.1016/s0168-8278(01)00092-7